Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 1 |
2012 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study.
Int J Clin Pract. 2011 Jan;65(1):64-72. doi: 10.1111/j.1742-1241.2010.02551.x. Epub 2010 Nov 22.
Int J Clin Pract. 2011.
PMID: 21091595
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.
Hörl WH, Locatelli F, Haag-Weber M, Ode M, Roth K; Epo-PASS study group.
Hörl WH, et al.
Clin Nephrol. 2012 Jul;78(1):24-32. doi: 10.5414/cn107440.
Clin Nephrol. 2012.
PMID: 22732334
Clinical Trial.
Item in Clipboard
Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis.
Haag-Weber M, Vetter A, Thyroff-Friesinger U; INJ-Study Group.
Haag-Weber M, et al.
Clin Nephrol. 2009 Nov;72(5):380-90.
Clin Nephrol. 2009.
PMID: 19863881
Clinical Trial.
Item in Clipboard
Cite
Cite